首页> 外国专利> THERAPY FOR THE PROPHYLAXIS OR TREATMENT OF ADVERSE BODY COMPOSITION CHANGES AND/OR DECREASED MUSCLE STRENGTH AFTER ANDROGEN OR GNRH ANALOGUE INTAKE

THERAPY FOR THE PROPHYLAXIS OR TREATMENT OF ADVERSE BODY COMPOSITION CHANGES AND/OR DECREASED MUSCLE STRENGTH AFTER ANDROGEN OR GNRH ANALOGUE INTAKE

机译:雄激素或GNRH模拟输入后不良身体组成变化和/或肌肉强度降低的预防性治疗或治疗

摘要

Methods of treating or reducing the risk of one or more effects or signs of induced hypogonadism after androgen or GnRH intake are disclosed herein. In an embodiment, a method of treating one or more effects after androgen or gonadotropin releasing hormone (GnRH) analogue intake comprises administering to a male subject at least one of a blocking compound which antagonizes estradiol binding to estradiol receptors or an inhibitor compound which inhibits endogenous production of estradiol, after androgen or gonadotropin releasing hormone (GnRH) analogue intake, to treat the one or more effects. The one or more effects include adverse body composition changes, decreased muscle strength, or both. The inhibitor compound and/or blocking compound may include antiestrogen agents, aromatase inhibitors, or combinations thereof.
机译:本文公开了在雄激素或GnRH摄入后治疗或降低诱导性腺功能减退的一种或多种作用或体征的风险的方法。在一个实施方案中,一种治疗雄激素或促性腺激素释放激素(GnRH)类似物摄入后的一种或多种作用的方法,包括对男性受试者给予至少一种拮抗雌二醇与雌二醇受体结合的阻断化合物或抑制内源性的抑制剂化合物。在雄激素或促性腺激素释放激素(GnRH)类似物摄入后产生雌二醇,以治疗一种或多种作用。一种或多种作用包括不利的身体组成变化,肌肉力量下降或两者兼而有之。抑制剂化合物和/或封闭化合物可包括抗雌激素剂,芳香酶抑制剂或其组合。

著录项

  • 公开/公告号US2009215733A1

    专利类型

  • 公开/公告日2009-08-27

    原文格式PDF

  • 申请/专利权人 MICHAEL CHARLES SCALLY;

    申请/专利号US20090391338

  • 发明设计人 MICHAEL CHARLES SCALLY;

    申请日2009-02-24

  • 分类号A61K31/566;A61K31/138;A61K31/4196;

  • 国家 US

  • 入库时间 2022-08-21 19:36:06

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号